Zostavax Related Clinical Trials
ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors [Not yet recruiting]
Systems Biology of Zoster Vaccine (ZOSTAVAX�) in Young and Elderly [Completed]
ZOSTAVAX(R) Local Registration Trial (V211-019) [Completed]
Herpes Zoster Vaccine for Bone Marrow Transplant Donors [Recruiting]
Zostavax in Systemic Lupus Erythematosus [Completed]
ZOSTAVAX® in Renal Transplant Patients [Active, not recruiting]
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy [Completed]
Zostavax in Rheumatoid Arthritis [Recruiting]
A Study of an Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014) [Completed]
Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds [Recruiting]
Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy [Suspended]
Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese Adults [Completed]
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects [Completed]
Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects [Completed]
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A [Active, not recruiting]
Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents [Active, not recruiting]
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older [Completed]
Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007) [Completed]
Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study [Withdrawn]
A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate [Completed]
Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects [Completed]
Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates [Completed]
Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) When Co-administered With GSK Biologicals' Diphtheria, Tetanus and Pertussis Vaccine (Boostrix®) in Adults Aged 50 Years and Older [Active, not recruiting]
Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines [Completed]
Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus Vaccine [Not yet recruiting]
iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma/VEGAS [Recruiting]
A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With HM Receiving Treatment With Anti-CD20 Monoclonal Antibodies (V212-013) [Completed]
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant [Recruiting]
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011) [Active, not recruiting]
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (Study No. V212-001 AM4) [Active, not recruiting]
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy [Active, not recruiting]
Month 30 & 42 Extension Studies of CRD-004 Primary Study [Completed]
Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009) [Completed]
Immune Response to Varicella-Zoster Vaccination and Infection [Completed]
Increasing Use of the Vaccine Against Herpes Zoster/Shingles at NYULMC and Bellevue Hospital [Completed]
|